Kayne Anderson Rudnick Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-59
Closed -$6K 658
2019
Q3
$6K Hold
59
﹤0.01% 422
2019
Q2
$5K Buy
+59
New +$5.6K ﹤0.01% 432
2017
Q4
Sell
-299,013
Closed -$43.6M 344
2017
Q3
$43.6M Sell
299,013
-5,155
-2% -$702K 0.39% 77
2017
Q2
$39.5M Sell
304,168
-5,725
-2% -$701K 0.39% 80
2017
Q1
$38.6M Sell
309,893
-7,916
-2% -$947K 0.42% 75
2016
Q4
$36.8M Sell
317,809
-10,747
-3% -$1.2M 0.44% 66
2016
Q3
$34.3M Buy
328,556
+131,687
+67% +$14.3M 0.43% 70
2016
Q2
$19.4M Buy
196,869
+31,364
+19% +$3.24M 0.29% 91
2016
Q1
$16.6M Sell
165,505
-2,457
-1% -$253K 0.27% 102
2015
Q4
$20.1M Sell
167,962
-1,807
-1% -$209K 0.33% 85
2015
Q3
$18.4M Buy
169,769
+29,299
+21% +$3.64M 0.31% 83
2015
Q2
$16.3M Sell
140,470
-2,194
-2% -$251K 0.25% 108
2015
Q1
$16.4M Sell
142,664
-2,687
-2% -$321K 0.25% 107
2014
Q4
$16.3M Sell
145,351
-3,646
-2% -$385K 0.27% 99
2014
Q3
$14.1M Sell
148,997
-5,428
-4% -$490K 0.25% 119
2014
Q2
$13.3M Buy
154,425
+63,421
+70% +$4.82M 0.23% 123
2014
Q1
$6.35M Buy
+91,004
New +$7.21M 0.11% 158

Other funds holding CELG

Kayne Anderson Rudnick Investment Management's CELG Position: Q4 2019 in Review

Kayne Anderson Rudnick Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 59 shares — an estimated $6K sold.

Kayne Anderson Rudnick Investment Management first reported a position in CELG in Q1 2014 and held it in 17 quarters. The position peaked at $43.6M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Kayne Anderson Rudnick Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 59 Celgene Corp shares in Q4 2019, an estimated $6K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Celgene Corp in Q1 2014 and held it in 17 quarters.
  • Kayne Anderson Rudnick Investment Management's Celgene Corp position peaked at $43.6M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q4 2019, filed 13 Feb 2020.